跳至主要内容
临床试验/NCT06347380
NCT06347380已完成不适用

Usability Study of the FemPulse System

FemPulse Corporation2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2024年9月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
5
试验地点
2
主要终点
Patient Satisfaction

研究概览

简要总结

The objective of the study is to demonstrate that the FemPulse System can be used as indicated in the Instructions for Use (IFU), as applicable.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Females, defined as a person with a uterus and cervix, ≥21 years old, with a diagnosis of OAB and symptoms for more than 6 months, as confirmed by a physician
  • Able to read, comprehend, and reliably provide informed consent and study-related information.
  • Willing and able to comply with study required procedures and visits (e.g., maintaining consistent medication use, fluid intake, diary completion).
  • Has adequate cognitive and manual capabilities to operate the FemPulse System and other components (e.g., mobile app) as assessed by the investigator.

排除标准

  • Currently pregnant, was pregnant in the past 12 months or intending to conceive during the study period.
  • Plans to begin other OAB therapies or otherwise change their existing therapy regimen during the study period.
  • Not an appropriate study candidate as determined by investigator.

研究组 & 干预措施

Subjects receiving FemPulse System

Experimental

Subjects will receive the Ring for the treatment of their OAB symptoms

干预措施: FemPulse System (Device)

结局指标

主要结局

Patient Satisfaction

时间窗: 28 days

Proportion of subjects reporting satisfaction with the use of the FemPulse System

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验